EUVIMEDEUVIMED felfedezése
Crossref

Radiation Therapy in Indonesia: Estimating Demand as Part of a National Cancer Control Strategy

Steven Octavianus, Soehartati Gondhowiardjo

Applied Radiation Oncology · 2022-03-01

DOI: 10.37549/aro1306 ↗

At a glance

Journal article in Applied Radiation Oncology, published online on 2022-03-01. Written by Steven Octavianus and 1 co-authors. Cited 3 times so far (Crossref); 31 references.

AbsztraktBibliográfiai adatokCiteRelated studies

Abstract (original language)

Cancer is one of the most prevalent noncommunicable diseases after cardiovascular disease, and is a worldwide problem. 1 Data from the Institute for Health Metrics and Abstract Purpose: The International Agency for Research on Cancer (IARC) predicts that the burden of cancer will continue to increase over the next few decades. Based on the Indonesia Basic National Health Survey (RISKESDAS) in 2018, cancer prevalence has increased 28% from 1.4 per 1,000 (2013) to 1.8 per 1,000 in 2018. Given the burden and challenges of the problems resulting from cancer over time, a comprehensive and systematic effort and response from various sectors is needed in the form of a National Cancer Control Plan (NCCP). Cancer treatment is the most expensive part of a cancer control program, and cancer-specific health facilities, human resources, specialized equipment, and therapy all contribute a high cost. Radiation therapy (RT) is a primary and priority medical treatment needed for cancer care; more than 50% of cancer patients will need RT.

Methods

Cancer incidences were extracted from the International Agency for Research on Cancer GLOBOCAN database. The total population was based on the Central Bureau of Statistics of Indonesia. Several models based on published literature were used to estimate the number of patients requiring RT in each province and the demand for megavoltage machines in Indonesia.

Results

Based on these models, the need for additional RT centers is evident. Through various estimation methods, Indonesia is expected to need 265 to 427 megavoltage machines to provide RT access to all cancer patients in the country. Using the Indonesian Radiation Oncology Society (IROS) estimation model (conventional and hypofractionated RT) and megavoltage/million, with the 82 megavoltage machines available in 2020, the coverage of RT services in Indonesia (available RT machines / RT required) is 21.7% (conventional RT), 27.7% (hypofractionated RT) and 31% (megavoltage/million).

Conclusions

Access to RT is a necessity and global priority. In addition to more facilities, implementing high-quality and safe RT services is essential. Hypofractionated radiation therapy (HRT) may be one innovation and solution for overcoming the RT short-age and preparing for a growing number of cancer cases in the future.

Cite

APA

Octavianus, S., & Gondhowiardjo, S. (2022). Radiation Therapy in Indonesia: Estimating Demand as Part of a National Cancer Control Strategy. Applied Radiation Oncology. https://doi.org/10.37549/aro1306

Vancouver

Octavianus S, Gondhowiardjo S. Radiation Therapy in Indonesia: Estimating Demand as Part of a National Cancer Control Strategy. Applied Radiation Oncology. 2022. doi:10.37549/aro1306

BibTeX
@article{Octavianus2022,
  author = {Octavianus, Steven and Gondhowiardjo, Soehartati},
  title = {Radiation Therapy in Indonesia: Estimating Demand as Part of a National Cancer Control Strategy},
  journal = {Applied Radiation Oncology},
  year = {2022},
  doi = {10.37549/aro1306}
}
Start for free →